Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib.

Front Mol Biosci

Published: August 2021

[This corrects the article DOI: 10.3389/fmolb.2021.624366.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435779	PMC
http://dx.doi.org/10.3389/fmolb.2021.727969	DOI Listing

Publication Analysis

corrigendum neutrophil-to-lymphocyte

neutrophil-to-lymphocyte platelet-to-lymphocyte

platelet-to-lymphocyte ratios

ratios predictors

predictors outcomes

outcomes patients

patients unresectable

unresectable hepatocellular

hepatocellular carcinoma

carcinoma undergoing

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!